Frank Stokes
Net Worth

Last updated:

What is Frank Stokes net worth?

The estimated net worth of Mr. Frank Stokes is at least $8,364,009 as of 10 Dec 2024. He owns shares worth $613,378 as insider, has earned $4,469,331 from insider trading and has received compensation worth at least $3,281,300 in Castle Biosciences, Inc..

What is the salary of Frank Stokes?

Mr. Frank Stokes salary is $656,260 per year as Chief Financial Officer in Castle Biosciences, Inc..

How old is Frank Stokes?

Mr. Frank Stokes is 55 years old, born in 1970.

What stocks does Frank Stokes currently own?

As insider, Mr. Frank Stokes owns shares in one company:

Company Title Shares Price per share Total value
Castle Biosciences, Inc. (CSTL) Chief Financial Officer 30,823 $19.9 $613,378

What does Castle Biosciences, Inc. do?

Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company also offers DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma, a rare eye cancer; DecisionDx-SCC, a proprietary 40-gene expression profile test that uses an individual patient's tumor biology to predict individual risk of squamous cell carcinoma metastasis for patients with one or more risk factors; and DecisionDx DiffDx-Melanoma and myPath Melanoma, a proprietary GEP test to diagnose suspicious pigmented lesions. It offers test services through physicians and their patients. The company was founded in 2007 and is headquartered in Friendswood, Texas.

CSTL logo
CSTL
Castle Biosciences, Inc.
$19.9

Frank Stokes insider trading

Castle Biosciences, Inc.

Mr. Frank Stokes has made 14 insider trades between 2020-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 14,617 units of CSTL stock on 9 Dec 2023. As of 10 Dec 2024 he still owns at least 30,823 units of CSTL stock.

Transaction Date Security Shares Price per share Total value Source
Option
Restricted Stock Units 6,169 N/A N/A
Option
Common Stock 2,000 N/A N/A
Option
Common Stock 6,169 N/A N/A
Option
Restricted Stock Units 2,000 N/A N/A
Option
Restricted Stock Units 14,617 N/A N/A
Option
Common Stock 14,617 N/A N/A
Sale
Common Stock 6,123 $29.87 $182,894
Sale
Common Stock 800 $30.4 $24,323
Option
Common Stock 6,170 N/A N/A
Option
Restricted Stock Units 2,000 N/A N/A
Option
Restricted Stock Units 6,170 N/A N/A
Option
Common Stock 2,000 N/A N/A
Option
Common Stock 14,617 N/A N/A
Option
Restricted Stock Units 14,617 N/A N/A
Option
Common Stock 4,000 $3.38 $13,520
Option
Stock option (right to buy) 4,000 $3.38 $13,520
Option
Common Stock 6,170 N/A N/A
Option
Restricted Stock Units 2,000 N/A N/A
Option
Common Stock 2,000 N/A N/A
Option
Restricted Stock Units 6,170 N/A N/A
Option
Common Stock 4,000 $3.38 $13,520
Option
Stock option (right to buy) 4,000 $3.38 $13,520
Option
Common Stock 2,000 N/A N/A
Option
Restricted Stock Units 2,000 N/A N/A
Sale
Common Stock 1,273 $73 $92,929
Option
Common Stock 1,273 $73 $92,929
Option
Stock option (right to buy) 1,273 $73 $92,929
Sale
Common Stock 2,127 $73.07 $155,420
Option
Stock option (right to buy) 2,127 $73.07 $155,420
Option
Common Stock 2,127 $73.07 $155,420
Option
Stock option (right to buy) 11,600 $2.39 $27,724
Option
Common Stock 11,600 $2.39 $27,724
Sale
Common Stock 11,600 $2.39 $27,724
Sale
Common Stock 7,500 $78.1 $585,750
Option
Stock option (right to buy) 7,500 $2.39 $17,925
Option
Common Stock 7,500 $2.39 $17,925
Sale
Common Stock 7,500 $78.26 $586,943
Option
Stock option (right to buy) 7,500 $2.39 $17,925
Option
Common Stock 7,500 $2.39 $17,925
Option
Common Stock 2,000 $3.38 $6,760
Option
Stock option (right to buy) 2,000 $3.38 $6,760
Option
Common Stock 13,000 $2.39 $31,070
Sale
Common Stock 13,000 $51.25 $666,250
Option
Stock option (right to buy) 13,000 $2.39 $31,070
Sale
Common Stock 13,000 $51.64 $671,294
Option
Common Stock 13,000 $2.39 $31,070
Option
Stock option (right to buy) 13,000 $2.39 $31,070
Option
Stock option (right to buy) 13,000 $2.39 $31,070
Sale
Common Stock 1,300 $55.13 $71,674
Sale
Common Stock 13,000 $54.26 $705,367
Option
Common Stock 13,000 $2.39 $31,070
Option
Common Stock 13,000 $2.39 $31,070
Option
Stock option (right to buy) 13,000 $2.39 $31,070
Sale
Common Stock 13,000 $2.39 $31,070
Option
Common Stock 13,000 $2.39 $31,070
Option
Stock option (right to buy) 13,000 $2.39 $31,070
Sale
Common Stock 13,000 $48.97 $636,623
Option
Common Stock 13,000 $2.39 $31,070
Sale
Common Stock 13,000 $2.39 $31,070
Option
Stock option (right to buy) 13,000 $2.39 $31,070

Castle Biosciences key executives

Castle Biosciences, Inc. executives and other stock owners filed with the SEC: